The indeterminate adrenal lesion

Cancer Imaging

Volumn 10, Issue 1, 2010, Pages 102-113

  Sahdev, Anju ^a   Willatt, Jon ^c   Francis, Isaac R ^c   Reznek, Rodney H ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenomas; Computed tomography (CT); Magnetic resonance imaging (MRI); Metastases; Positron emission tomography (PET)

Indexed keywords

ADRENAL CORTEX CARCINOMA; CANCER SIZE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ELECTRON SPIN RESONANCE; HUMAN; LIPID ANALYSIS; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; ADENOMA; ADRENAL GLAND; ADRENAL TUMOR; ADULT; BIOPSY; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ADULT; BIOPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951246330     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2010.0012     Document Type: Review

References (54)

1. Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL. Non-functioning adrenal masses: incidental discovery on computed tomography. AJR 1982; 139: 81-5.
2. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006; 29: 298-302. (Pubitemid 43905318)
3. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR 2008; 190: 1163-8. doi:10.2214/AJR.07.2799. PMid:18430826.
4. Libe R, Bertherat J. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases. Eur J Endocrinol 2005; 153: 477-87. doi:10.1530/eje.1.02004. PMid:16189167.
5. Oliver Jr TW, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in non small-cell bronchogenic carcinoma. Radiology 1984; 153: 217-8.
6. Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004; 136: 1289-96. doi:10.1016/j.surg.2004.06.060. PMid: 15657589.
7. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179: 415-8.
8. Francis IR, Casalino DD, Arellano RS, et al. ACR appropriateness criteria. Incidentally discovered adrenal mass. http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/app-criteria/pdf/ ExpertPanelonUrologicImaging/Incidentally DiscoveredAdrenalMassDoc7.aspx (accessed 1 December 2009).
9. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998; 171: 201-4.
10. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217: 798-802.
11. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996; 166: 531-6. (Pubitemid 26065155)
12. Blake MA, Krishnamoorthy SK, Boland GW, Sweeney AT, Pitman MB, Harisinghani M, et al. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 2003; 181: 1663-8.
13. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998; 207: 369-75.
14. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2006; 238: 578-85. doi:10.1148/radiol.2382041514. PMid:16371582.
15. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222: 629-33. doi:10.1148/radiol.2223010766. PMid:11867777.
16. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170: 747-52. (Pubitemid 28106677)
17. Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR 2002; 179: 559-68.
18. Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP. Adrenal masses: CT characterization with histogram analysis method. Radiology 2003; 228: 735-42. doi:10.1148/radiol.2283020878. PMid:12954893.
19. Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR. CT histogram analysis in pathologically proven adrenal masses. AJR 2006; 187: 191-6. doi:10.2214/AJR.05.0179. PMid:16794176.
20. Jhaveri KS, Wong F, Ghai S, Haider MA. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR 2006; 187: 1303-8. doi:10.2214/AJR.05.1022. PMid:17056920.
21. Halefoglu AM, Bas N, Yasar A, Basak M. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study. Eur J Radiol 2009; doi:10.1016/j.ejrad.2008.12.010.
22. Ho LM, Paulson EK, Brady MJ, Wong TZ, Schindera ST. Lipidpoor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR 2008; 191: 234-8. doi:10.2214/AJR.07.3150. PMid: 18562751.
23. Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH. Adrenal masses differentiated by MR. Radiology 1986; 158: 81-4.
24. Chang A, Glazer HS, Lee JK, Ling D, Heiken JP. Adrenal gland: MR imaging. Radiology 1987; 163: 123-8.
25. Glazer GM, Woolsey EJ, Borrello J, et al. Adrenal tissue characterization using MR imaging. Radiology 1986; 158: 73-9. (Pubitemid 16169430)
26. Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol 2008; 65: 154-62. doi:10.1016/j.ejrad. 2007.03.012. PMid: 17466481.
27. Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTP-enhanced dynamic studies. Radiology 1989; 171: 675-80.
28. Semelka RC, Shoenut JP, Lawrence PH, et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 1993; 3: 337-43. doi:10.1002/jmri.1880030208. PMid:8448395.
29. Chung JJ, Semelka RC, Martin DR. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging 2001; 13: 242-8. doi:10.1002/1522-2586(200102)13:25242::AID-JMRI103543.3.CO;2-R.
30. Ichikawa T, Ohtomo K, Uchiyama G, et al. Adrenal adenomas: characteristic hyperintense rim sign on fat-saturated spin-echo MR images. Radiology 1994; 193: 247-50.
31. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165: 91-5.
32. Dunnick NR, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR 1996; 167: 861-7.
33. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging. Radiology 1993; 186: 705.
34. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200: 743-7.
35. Al-Hawary MM, Francis IR, Korobkin M. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass. Best Pract Res Clin Endocrinol Metab 2005; 19: 277-92. doi:10.1016/j.beem.2004.09.002. PMid: 1788959816483008128498371284983511464239332 0538.
36. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR 2004; 183: 215-9. (Pubitemid 38789040)
37. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (410 HU) adrenal masses: does it still have a role? Radiology 2004; 231: 711-6. doi:10.1148/radiol.2313030676. PMid:15118113.
38. Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E. Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR 2006; 186: 130-5. doi:10.2214/AJR.04.1370. PMid:16357391.
39. Lowe VJ, Naunheim KS. Current role of positron emission tomography in thoracic oncology. Thorax 1998; 53: 703-12. doi:10.1136/thx.53.8.703. PMid:9828860.
40. Erasmus JJ, McAdams HP, Patz Jr EF. Non-small cell lung cancer: FDG-PET imaging. J Thorac Imaging 1999; 14: 247-56. doi:10.1097/00005382-199910000- 00004. PMid: 10524805.
41. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42: 1795-9. (Pubitemid 34016347)
42. Boland GW, Blake MA, Holalkere NS, Hahn PF. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR 2009; 192: 956-62. doi:10.2214/AJR.08.1431. PMid:19304700.
43. 18F- Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 2009; 94: 1713-22. doi:10.1210/jc.2008-2302.
44. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT quantitative and qualitative evaluation. Acad Radiol 2007; 14: 468-75. doi:10.1016/j.acra.2007. 01.009. PMid:17368217.
45. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 2006; 238: 9707.
46. Chong S, Lee KS, Kim HY, et al. Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 2006; 26: 1811-24. doi:10.1148/rg.266065057. PMid:17102052.
47. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions. AJR 1999; 173: 25-9.
48. Hennings J, Lindhe O, Bergstrom M, Langstrom B, Sundin A, Hellman P. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006; 91: 1410-4. doi:10.1210/jc.2005-2273.
49. Harisinghani MG, Maher MM, Hahn PF, et al. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol 2002; 57: 898-901. doi:10.1053/crad.2002.1054. PMid: 12413913.
50. Welch TJ, Sheedy 2nd PF, Stephens DH, Johnson CM, Swensen SJ. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 1994; 193: 341-4.
51. Mody MK, Kazerooni EA, Korobkin M. Percutaneous CT-guided biopsy of adrenal masses: immediate and delayed complications. J Comput Assist Tomogr 1995; 19: 434-9.
52. Vincent JM, Morrison ID, Armstrong P, Reznek RH. Computed tomography of diffuse, non-metastatic enlargement of the adrenal glands in patients with malignant disease. Clin Radiol 1994; 49: 456-60. doi:10.1016/S0009-9260(05) 81740-4.
53. Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R. Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 1999; 80: 1815-9. doi:10.1038/sj.bjc.6690603. PMid:10468302.
54. Benitah N, Yeh BM, Qayyum A, Williams G, Breiman RS, Coakley FV. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology 2005; 235: 517-22. doi:10.1148/radiol. 2352031708. PMid:15858092.